Back to CBIO

Vestal Point Capital, LP → CBIO

Vestal Point Capital, LP CBIO Position History

Crescent Biopharma, Inc. • Healthcare

Quarters held
4
Latest value
$43.8M
Q3 2026
Peak value
$43.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$17.8M
Q1 2026$27.6M
Q2 2026$29.3M
Q3 2026$43.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$43.8M3.00M——
Q2 2026$29.3M1.63M——
Q1 2026$27.6M1.50M——
Q4 2025$17.8M1.50M——

Other funds holding CBIO

Other Vestal Point Capital, LP positions

AAVXF

Abivax SA

$392.1M
NBIX

Neurocrine Biosciences Inc

$354.6M
BMRN

BioMarin Pharmaceutical Inc

$344.8M
BMRN

BioMarin Pharmaceutical Inc

$331.5M
NBIX

Neurocrine Biosciences Inc

$316.8M
ARWR

Arrowhead Pharmaceuticals Inc

$315.1M
AAVXF

Abivax SA

$313.1M
INSM

Insmed Inc

$311M